Accuray's President, CEO and Director of the Board, Euan S. Thomson, has resigned. Accuray's Board has appointed Joshua H. Levine as his successor as president, CEO and director of the board, effective immediately. Thomson is anticipated to continue in a consulting role with the company.
Thomson joined Accuray in March 2002 as CEO, was appointed president in September 2002 and served on the board of directors. During his tenure, Thomson expanded the radiosurgery market with the company's product, the CyberKnife System. He took the company public in February 2007 and led the company through the acquisition of TomoTherapy in 2011. Sunnyvale-based Accuray said the addition of the TomoTherapy system to the its product portfolio expanded the company into the radiation therapy market.
Levine was CEO of Mentor where he was instrumental in its sale to a franchise of Johnson & Johnson in January 2009, and more recently was CEO of Immucor until October 2011, when it was acquired by TPG Capital.